Edgewise Therapeutics (EWTX) Other Non-Current Assets (2020 - 2025)
Edgewise Therapeutics' Other Non-Current Assets came in at $695,000 for Q1 2025, up 165.3% from the prior quarter.
Powered by 
Analysis
Edgewise Therapeutics (EWTX) Other Non-Current Assets (2020 - 2025) Analysis & Trends
At the end of FY2024, Edgewise Therapeutics' Other Non-Current Assets was $262,000, down 24.7% from FY2023.
- Other Non-Current Assets carries a four-year compound annual growth rate of -28.0% (FY2020 to FY2024).
- Going back by year, Other Non-Current Assets was $348,000 in FY2023 (+38.6%), $251,000 in FY2022 (-54.2%), $548,000 in FY2021 (-43.8%) and $975,000 in FY2020.
- The Q1 2025 figure represents the highest quarterly Other Non-Current Assets since Q4 2020.
- Year-over-year, Other Non-Current Assets increased in two of the last six quarters, with growth averaging 0.5%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q1 2022 (growth of 178.1%), and the weakest in Q1 2023 (a decline of 55.1%).
- Business Quant data shows EWTX's Other Non-Current Assets at $262,000 (Q4 2024), $262,000 (Q3 2024) and $262,000 (Q2 2024) in the three quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Edgewise Therapeutics | 4.38 Bn | 4.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 695,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Sep 30, 2024 | 262,000.00 |
| Jun 30, 2024 | 262,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 467,000.00 |
| Jun 30, 2023 | 419,000.00 |
| Mar 31, 2023 | 251,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 447,000.00 |
| Mar 31, 2022 | 559,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Sep 30, 2021 | 295,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 975,000.00 |
API Access
Edgewise Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EWTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "EWTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EWTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();